BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24145113)

  • 1. Genetic profiling to predict recurrence of early cervical cancer.
    Lee YY; Kim TJ; Kim JY; Choi CH; Do IG; Song SY; Sohn I; Jung SH; Bae DS; Lee JW; Kim BG
    Gynecol Oncol; 2013 Dec; 131(3):650-4. PubMed ID: 24145113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
    Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil.
    Brenna SM; Silva ID; Zeferino LC; Pereira JS; Martinez EZ; Syrjänen KJ
    Gynecol Oncol; 2004 May; 93(2):374-80. PubMed ID: 15099948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of existing prognostic models in patients with early-stage cervical cancer.
    Biewenga P; van der Velden J; Mol BW; Stalpers LJ; Schilthuis MS; van der Steeg JW; Burger MP; Buist MR
    Gynecol Oncol; 2009 Nov; 115(2):277-84. PubMed ID: 19740531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
    Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
    J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
    Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
    J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
    Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
    Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy.
    Shinohara S; Ochi T; Miyazaki T; Fujii T; Kawamura M; Mochizuki T; Ito M
    Int J Clin Oncol; 2004 Dec; 9(6):503-9. PubMed ID: 15616882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.
    Bauer JJ; Connelly RR; Seterhenn IA; Deausen J; Srivastava S; McLeod DG; Moul JW
    J Urol; 1998 Mar; 159(3):929-33. PubMed ID: 9474185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
    Distefano M; Ferrandina G; Smaniotto D; Margariti AP; Zannoni G; Macchia G; Manfredi R; Mangiacotti MG; Cellini N; Scambia G
    Oncology; 2004; 67(2):103-11. PubMed ID: 15539913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
    Eggen T; Arnes M; Moe B; Straume B; Orbo A
    Int J Gynecol Pathol; 2007 Oct; 26(4):447-56. PubMed ID: 17885497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.